Clinical Trials Logo

Clinical Trial Summary

The blinded resection avoided in case of pancreatic insulinoma


Clinical Trial Description

Despite of the technique and technology developement there are still a lot of troubles to verify small benign-looking pancreatic NETs. It can be especially important in case of insulinoma. The organic hyperilsulinism and severe hypoglicemia causeb by the insulin/proinsulin - producing lesion can lead to severe complications and evem death. There are some cases of the blinded resections of the pancreas in patients with the "hidden" insulinoma when the tumor can't be revealed during the preoperative diagnostics and intraoperatively. Unfortunately, blind resection do not solve the problem of the hypoglicemia but also cause the specific pancreatic complications. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04741152
Study type Observational [Patient Registry]
Source Vishnevsky Center of Surgery
Contact
Status Completed
Phase
Start date January 2010
Completion date December 2020